Key result
Percutaneous coronary intervention is more cost-effective than medical therapy for reducing mortality and improving quality of life, whereas medical therapy is more cost-effective overall.
Why the study?
Controversies remain regarding the most appropriate treatment strategy for patients with ischemic heart disease.
Is percutaneous coronary intervention more cost-effective than medical therapy in patients with ischemic heart disease?
Is percutaneous coronary intervention more cost-effective than medical therapy in patients with ischemic heart disease?
This cost-effectiveness analysis presents conflicting statements regarding whether PCI or medical therapy is more cost-effective for ischemic heart disease.
Conflicting cost-effectiveness claims in this Level 5 analysis leave the preferred strategy unresolved; higher-quality trials needed before practice implications.
According to this study, PCI is more cost-effective than medical therapy in the reduction of mortality rate and in the field of increasing quality of life. MT strategy is more cost-effective than the PCI. This study considers controversies regarding the most appropriate treatment for patients with ischemic heart disease that is helpful for health policymakers, cardiologists and health managers.
No takes yet. Share an insight, caveat, or question.
Rezapour et al. (2020) studied this question. Percutaneous coronary intervention is more cost-effective than medical therapy for reducing mortality and improving quality of life, whereas medical therapy is more cost-effective overall.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: